Evaluation of Elicit as an adjunct search, screening, and data extraction tool for systematic reviews
Wei, I.; Shah, J. N.; Miah, A.; Hawco, C.; Coutts, F.; Sikstrom, L.; Ameis, S. H.; Voineskos, A. N.; Glatard, T.; Dickie, E. W.
Show abstract
Background: Systematic reviews are critical for informing evidence-based medicine, policy, and future research. However, conducting a systematic review is labour- and cost-intensive and error-prone. Elicit is an AI tool that claims to replicate the systematic review process. Methods: Our study investigated Elicit's ability to replicate a systematic review by comparing its results with those of an existing systematic review recently published by our research group. We calculated accuracy, precision, sensitivity, error rate, and person-time savings at each stage of the systematic review. Results: At search, Elicit had poor overlap, finding 158 of the 5285 studies. For abstract and full-text screening, Elicit had moderate sensitivity and accuracy but poor precision, with a skew toward false positives. Elicit's data extraction tool was promising, with sentence-specific citations, and provided helpful information for 85% of values even when it did not find exact matches. Elicit offered person-time savings, taking 3.16 hours to complete the full systematic review process. Conclusions: Elicit shows promise as an adjunct screening and extraction AI tool, but in its current form, it is not ready as a standalone tool to replace the systematic review process.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- To Include or Not to Include? A prescription from the pharmacy on how to use active learning assisted screening in systematic reviews 96%
- Repurposing Existing Medications for Coronavirus Disease 2019: Protocol for a Rapid and Living Systematic Review 93%
- Evidence-Based, Cost-Effective Interventions To Suppress The COVID-19 Pandemic: A Systematic Review 93%
Similar papers in this journal
- Evaluation of the sensitivity, accuracy and currency of the Cochrane COVID-19 Study Register for supporting rapid evidence synthesis production 96%
- Exploring the potential of Claude 2 for risk of bias assessment: Using a large language model to assess randomized controlled trials with RoB 2 96%
- Evaluation of the replicability of systematic reviews with meta-analyses of the effects of health interventions 96%
Similar papers in this journal
- Exploring scalable assessment methods for terminated trials in ClinicalTrials.gov: A cohort analysis of German and Californian trials 93%
- Modelling the impact of behavioural interventions during pandemics: A systematic review 93%
- COVID-19-related research data availability and quality according to the FAIR principles: A meta-research study 92%
Similar papers in this journal
- Erroneous risks in pharmaceutical versus non-pharmaceutical interventions during data extraction in evidence synthesis practice: Study protocol for a randomized controlled trial 94%
- A Retrospective Analysis of Serious Adverse Events and Deaths in US-Based Lifestyle Clinical Trials for Cognitive Health 89%
- The IGNITE Trial: Participant Recruitment Lessons Prior to SARS-CoV-2 89%
Similar papers in this journal
- Incorporating Preprints in Systematic Reviews: A Preliminary Study of a Novel Method for Rapid Evidence Synthesis 98%
- A Web-based Tool for Automatically linking Clinical Trials to their Publications 92%
- Beyond Metrics to Methods: A Scoping Review of Large Language Models for Detection of Social Drivers of Health in Clinical Notes 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.